We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
EPTIFIBATIDE MEDICIANZ (Medsurge Pharma Pty Ltd)
Product name
EPTIFIBATIDE MEDICIANZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
126 (255 working days)
Active ingredients
eptifibatide
Registration type
New generic medicine
Indication
TRADE NAME is indicated for patients undergoing nonurgent percutaneous coronary intervention with intracoronary stenting (see Section 5.1 Pharmacodynamic Properties, Clinical trials).
TRADE NAME is indicated for the treatment of patients with unstable angina or non-Q-wave myocardial infarction (see Section 5.1 Pharmacodynamic Properties, Clinical trials).